- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 17 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 31 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.18: 4 residues within 4Å:- Chain A: N.123, A.124, T.125, N.126
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain A: F.341, N.342, F.370
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: N.330, Q.578
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: N.614, T.616, E.617
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain A: N.655
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: S.706, N.707
- Chain C: Y.794
Ligand excluded by PLIPNAG.24: 5 residues within 4Å:- Chain A: A.704, E.1070, K.1071, N.1072
- Chain C: Q.893
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain A: Y.31, T.32, N.33, N.64
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain A: N.165
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain A: G.231, N.233
Ligand excluded by PLIPNAG.28: 6 residues within 4Å:- Chain B: N.123, T.125, N.126, V.127, F.128, V.171
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain B: Y.31, F.62, N.64
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain B: S.113, E.133, N.164, N.165
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain B: T.109, N.233, T.235
- Chain C: E.464
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain B: N.330, Q.578, T.579
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: N.614, T.616
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.655
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain A: Y.794
- Chain B: S.706, N.707
Ligand excluded by PLIPNAG.36: 4 residues within 4Å:- Chain A: Q.893
- Chain B: A.704, E.1070, N.1072
Ligand excluded by PLIPNAG.37: 5 residues within 4Å:- Chain B: E.339, R.345, A.347, N.353, T.355
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain B: H.338, F.341, N.342, F.370
Ligand excluded by PLIPNAG.39: 5 residues within 4Å:- Chain C: N.123, A.124, T.125, N.126, V.171
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain C: Y.31, F.62, N.64
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: N.164, N.165
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain C: N.614, T.616
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain C: N.655
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain B: I.792, Y.794
- Chain C: S.706, N.707
Ligand excluded by PLIPNAG.45: 5 residues within 4Å:- Chain B: Q.893
- Chain C: A.704, E.1070, K.1071, N.1072
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain C: N.342, T.344
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain A: E.464
- Chain C: T.109, N.233, T.235
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain C: N.330, P.577, Q.578
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, P. et al., Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity. Natl Sci Rev (2024)
- Release Date
- 2024-07-03
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 17 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 31 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, P. et al., Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity. Natl Sci Rev (2024)
- Release Date
- 2024-07-03
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C